[Federal Register Volume 59, Number 240 (Thursday, December 15, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-30871]


[[Page Unknown]]

[Federal Register: December 15, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary

 

Findings of Scientific Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has made final findings of scientific misconduct in the following 
case:
    Gerald Leisman, Ph.D., New York Chiropractic College: The Division 
of Research Investigations (DRI) of the Office of Research Integrity 
(ORI) reviewed an investigation conducted by the New York Chiropractic 
College (NYCC) into possible scientific misconduct on the part of 
Gerald Leisman, Ph.D., formerly Director of Research and Institutes at 
NYCC. ORI found that Dr. Leisman committed scientific misconduct by 
misrepresenting his academic credentials and professional experience 
and awards in a grant application (T32 AR07564-01A1) for Public Health 
Service (PHS) research funds submitted on December 29, 1988. Based upon 
information obtained by ORI during its oversight review, the ORI found 
that Dr. Leisman falsely claimed: (1) To have earned a M.D. degree from 
the University of Manchester (Manchester, England) in 1972; (2) to have 
held the position of Professor, Neurology and Biomedical Engineering, 
Harvard University Medical School (June 1982 to January 1987); and (3) 
to have been awarded inventorship or co-inventorship of thirteen (13) 
U.S. Patents. Dr. Leisman accepted the ORI findings and agreed to a 
Voluntary Exclusion agreement under which he is not eligible to apply 
for or receive any Federal funds in non-procurement transactions (e.g., 
grants and co-operative agreements) and is not eligible to contract or 
subcontract with any Federal Government Agency for a three-year period 
beginning November 28, 1994 and ending November 27, 1997. In addition, 
Dr. Leisman is prohibited from serving on PHS Advisory Committees, 
Boards, or peer review groups for a three-year period beginning 
November 28, 1994 and ending November 27, 1997.

FOR FURTHER INFORMATION CONTACT:
Director, Division of Research Investigations, Office of Research 
Integrity, 301-443-5330.
Lyle W. Bivens, Ph.D.,
Director, Office of Research Integrity.
[FR Doc. 94-30871 Filed 12-14-94; 8:45 am]
BILLING CODE 4160-17-M